Screener
Ionis Pharmaceuticals IONS Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Investment income | 20,230 | 24,687 | 45,713 | 49,354 |
| Interest expense | (4,618) | (4,114) | (9,778) | (8,223) |
| Interest expense related to sale of future royalties | (17,506) | (18,648) | (34,843) | (37,470) |
| Gain (loss) on investments, net | (10,182) | (18,312) | 12,401 | (20,476) |
| Other income, net | 987 | 102 | 529 | 569 |
| Income (loss) before income tax benefit (expense) | (113,382) | 123,531 | (205,692) | (23,291) |
| Income tax benefit (expense) | (1,264) | 20 | (1,482) | (96) |
| Net income (loss) | $$(114,646) | $123,551 | $(207,174) | (23,387) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's net gains (losses) on investments?
- Ionis Pharmaceuticals (IONS) reported net gains (losses) on investments of -$10.18M in Q2 2026.
- How has Ionis Pharmaceuticals's net gains (losses) on investments changed year-over-year?
- Ionis Pharmaceuticals's net gains (losses) on investments increased by 44.4% year-over-year, from -$18.31M to -$10.18M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Ionis Pharmaceuticals's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude